Mesoblast Limited
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Mesoblast Limited now
Current reporting with the operating signal separated from the noise.
Why Mesoblast Limited’s (MESO) Stock Is Down 6.49%
Investors are testing whether Mesoblast Limited’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Mesoblast Limited (MESO) Q2 2026 Earnings Call Transcript
Investors are testing whether Mesoblast Limited’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Mesoblast Limited (MESO) Q4 2025 Earnings Call Transcript
Investors are testing whether Mesoblast Limited’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest MESO filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Mesoblast Limited, quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →